- Home
- AZZ vs PTGX Comparison
AZZ vs PTGX Comparison
Compare AZZ & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZZ
- PTGX
- Stock Information
- Founded
- AZZ 1956
- PTGX 2006
- Country
- AZZ United States
- PTGX United States
- Employees
- AZZ N/A
- PTGX N/A
- Industry
- AZZ Industrial Specialties
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- AZZ Industrials
- PTGX Health Care
- Exchange
- AZZ Nasdaq
- PTGX Nasdaq
- Market Cap
- AZZ 3.3B
- PTGX 3.3B
- IPO Year
- AZZ N/A
- PTGX 2016
- Fundamental
- Price
- AZZ $112.86
- PTGX $58.97
- Analyst Decision
- AZZ Buy
- PTGX Strong Buy
- Analyst Count
- AZZ 6
- PTGX 8
- Target Price
- AZZ $109.67
- PTGX $70.13
- AVG Volume (30 Days)
- AZZ 284.7K
- PTGX 646.3K
- Earning Date
- AZZ 10-08-2025
- PTGX 08-06-2025
- Dividend Yield
- AZZ 0.60%
- PTGX N/A
- EPS Growth
- AZZ 908.98
- PTGX N/A
- EPS
- AZZ 8.62
- PTGX 0.80
- Revenue
- AZZ $1,586,498,000.00
- PTGX $209,180,000.00
- Revenue This Year
- AZZ $6.99
- PTGX N/A
- Revenue Next Year
- AZZ $4.09
- PTGX $185.11
- P/E Ratio
- AZZ $13.05
- PTGX $73.40
- Revenue Growth
- AZZ 1.70
- PTGX N/A
- 52 Week Low
- AZZ $70.90
- PTGX $33.31
- 52 Week High
- AZZ $117.35
- PTGX $61.89
- Technical
- Relative Strength Index (RSI)
- AZZ 53.48
- PTGX 57.69
- Support Level
- AZZ $114.66
- PTGX $55.26
- Resistance Level
- AZZ $117.00
- PTGX $58.79
- Average True Range (ATR)
- AZZ 2.61
- PTGX 2.20
- MACD
- AZZ -0.29
- PTGX 0.39
- Stochastic Oscillator
- AZZ 34.45
- PTGX 66.84
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.